This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)
C3_SECONDARY_WITHOUT_SITESPEC_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1827 |
4. Check minimum number of eventsNone |
1827 |
5. Include endpointsNone |
1827 |
6. Filter based on genotype QC (FinnGen only) |
1827 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1827 | 750 | 1077 |
| Unadjusted period prevalence (%) | 0.38 | 0.26 | 0.47 |
| Median age at first event (years) | 70.57 | 69.11 | 71.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1122
- Matched controls
- 11218
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
362
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
314.8
287
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
257.4
237
*
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
205.7
191
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
197.9
184
*
H02AB02
ATC
dexamethasone; systemic
55.6
185.6
220
49
A03FA01
ATC
metoclopramide; systemic, rectal
9.5
175.3
409
636
JN4BD
NOMESCO Finland
Extensive body CT
15.5
146.7
253
206
A04AA02
ATC
granisetron; systemic, transdermal
+∞
146.1
137
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
139.5
131
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
134.1
126
*
Z51.5
ICD-10 Finland
Palliative care
17.6
127.9
208
143
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
122.1
115
*
N02AA05
ATC
oxycodone; systemic
6.4
121.0
369
792
8070/3-C80.9
ICD-O-3
Squamous cell carcinoma, NOS, of unknown primary site
+∞
114.6
108
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
113.5
107
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
113.5
107
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
102.7
97
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
1011.0
96.4
93
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
89.8
85
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
89.8
85
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
200.1
89.7
92
5
8010/3-C80.9
ICD-O-3
Carcinoma, NOS, of unknown primary site
+∞
88.7
84
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
84.4
80
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
84.4
80
*
A04AA01
ATC
ondansetron; systemic, rectal
22.9
83.9
123
60
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
83.4
79
*
WF002
NOMESCO Finland
Radical radiotherapy
178.9
80.2
83
5
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
21.6
78.5
117
60
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
74.8
71
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
71.6
68
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
71.6
68
*
116
Kela drug reimbursment
Prostate cancer
+∞
67.4
64
*
JN4AD
NOMESCO Finland
Body CT examination
10.0
65.6
137
154
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
64.2
61
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
32.6
62.2
82
27
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
62.0
59
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
61.0
58
*
L03AA02
ATC
filgrastim; parenteral
295.6
55.7
56
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
55.3
341
1302
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.4
53.2
122
160
C80.9
ICD-10 Finland
Malignant neoplasm, primary site unspecified
+∞
51.4
49
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
50.4
48
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.4
50.0
125
187
JN4CD
NOMESCO Finland
Very extensive body CT
15.6
49.9
83
57
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
49.3
47
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
48.3
46
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
23.3
47.2
68
31
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
46.1
44
*
L01BC06
ATC
capecitabine; oral
+∞
46.1
44
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
45.1
43
*
8246/3-C80.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of unknown primary site
+∞
44.0
42
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
43.0
41
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
16.8
42.2
68
43
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
41.9
40
*
L02AE02
ATC
leuprorelin; implant, parenteral
114.3
41.0
44
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
39.8
38
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
38.8
37
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
37.7
36
*
WW500
NOMESCO Finland
Blood transfusion
9.2
36.6
78
90
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
368.5
36.2
36
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
357.8
35.1
35
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
34.5
33
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
34.5
33
*
8720/3-C80.9
ICD-O-3
Malignant melanoma, NOS, of unknown primary site
+∞
34.5
33
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
39.6
33.6
42
11
WZC30
NOMESCO Finland
Teaching
4.0
32.9
142
393
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
11.7
32.6
61
55
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
8.1
31.7
73
96
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
31.4
30
*
EMB10
NOMESCO Finland
Tonsillectomy
9.0
30.8
66
77
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
310.2
29.9
30
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.1
29.4
83
146
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
29.3
28
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
67.8
29.0
33
5
A79
ICPC
Malignancy NOS
299.2
28.9
29
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
153.9
28.8
30
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
153.9
28.8
30
*
XW000
NOMESCO Finland
Bone marrow biopsy
6.5
28.5
76
124
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
28.2
27
*
H01CB02
ATC
octreotide; parenteral
+∞
28.2
27
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
33.7
27.9
36
11
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
11.5
27.8
52
47
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
148.6
27.7
29
*
HA1AA
NOMESCO Finland
X-ray mammography
10.1
27.4
55
57
115
Kela drug reimbursment
Breast cancer
+∞
27.2
26
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
27.2
26
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
27.2
26
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
27.2
26
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
32.8
27.0
35
11
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
99.1
26.8
29
*
R18
ICD-10 Finland
Ascites
10.2
26.7
53
54
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.5
26.5
81
157
B01AB10
ATC
tinzaparin; parenteral
5.3
26.5
84
170
A04AD12
ATC
aprepitant; systemic
+∞
26.1
25
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
26.1
25
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
138.1
25.7
27
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
25.5
173
667
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
25.1
24
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.1
24
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
25.1
24
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
25.1
24
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
17.5
25.0
39
23
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
16.1
24.2
39
25
8480/3-C80.9
ICD-O-3
Mucinous adenocarcinoma of unknown primary site
+∞
24.0
23
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
24.0
23
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
24.0
23
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
24.0
23
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
23.1
350
2025
L02BB03
ATC
bicalutamide; oral
+∞
23.0
22
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
23.0
22
*
UJC01
NOMESCO Finland
Scopy of lower throat
15.9
22.9
37
24
ZX120
NOMESCO Finland
Intravenous
3.3
22.8
120
389
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
22.4
130
449
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
21.9
21
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
21.9
21
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
21.9
21
*
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
+∞
21.9
21
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
21.9
21
*
8240/3-C80.9
ICD-O-3
Neuroendocrine tumor, NOS, of unknown primary site
+∞
21.9
21
*
L02BG04
ATC
letrozole; oral
63.8
21.9
25
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
21.7
252
1294
JDB10
NOMESCO Finland
Percutaneous gastrostomy
11.5
21.5
40
36
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.0
21.4
135
495
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
20.9
20
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
20.9
20
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
20.9
20
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
20.9
20
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
78.3
20.7
23
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.5
20.6
74
172
ZX112
NOMESCO Finland
Subcutaneous
23.9
20.0
28
12
8041/3-C80.9
ICD-O-3
Small cell carcinoma, NOS, of unknown primary site
+∞
19.8
19
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
19.8
19
*
8249/3-C80.9
ICD-O-3
Neuroendocrine tumor, grade 2 of unknown primary site
+∞
19.8
19
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
19.8
19
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.6
19.7
38
37
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
19.4
171
763
J01MA12
ATC
levofloxacin; systemic
2.1
19.0
236
1238
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
15.1
19.0
31
21
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
18.8
18
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
18.8
18
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
18.8
18
*
L01AX03
ATC
temozolomide; systemic
+∞
18.8
18
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.5
18.8
56
106
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
71.1
18.7
21
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
71.1
18.7
21
*
R4190
NOMESCO Finland
Nutritional therapy
9.1
18.7
39
44
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
21.2
18.7
27
13
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.0
18.7
42
54
D77
ICPC
Malignant digestive neopl other/NOS
193.0
18.6
19
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
17.7
17
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
17.7
17
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
17.7
17
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
17.7
17
*
Y77
ICPC
Malignant neoplasm prostate
182.7
17.6
18
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
182.7
17.6
18
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
10.6
17.2
33
32
JN6AD
NOMESCO Finland
CT of torso and neck
50.8
17.0
20
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
17.0
97
333
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
16.7
16
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
16.7
16
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
16.7
16
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
16.7
16
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
16.7
16
*
E34.0
ICD-10 Finland
Carcinoid syndrome
172.4
16.5
17
*
1XC02
NOMESCO Finland
NA
28.0
16.5
22
8
A98
ICPC
Health maint/preventive medicine
0.6
16.5
605
7482
UDQ22
NOMESCO Finland
Microlaryngoscopy
13.0
16.2
28
22
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.7
15.9
26
18
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
15.7
15
*
8020/3-C80.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of unknown primary site
+∞
15.7
15
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
15.7
15
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
15.7
15
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
15.7
15
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
15.7
15
*
H01CB03
ATC
lanreotide; parenteral
+∞
15.7
15
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.9
15.4
38
57
B01AB05
ATC
enoxaparin; parenteral
1.8
15.3
290
1779
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.5
15.2
45
85
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
15.1
105
409
N02AX02
ATC
tramadol; systemic, rectal
1.7
15.0
437
3059
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.8
14.9
64
177
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
16.7
14.8
23
14
J94.8
ICD-10 Finland
Other specified pleural conditions
6.7
14.7
37
57
C50.99
ICD-10 Finland
Breast, unspecified
+∞
14.6
14
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
14.6
14
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
14.6
14
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
14.6
14
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
14.6
14
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
36.5
14.5
18
5
ZZR00
NOMESCO Finland
Flap of skin
14.6
14.1
23
16
UJF32
NOMESCO Finland
Coloscopy
1.8
13.8
262
1597
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
76.0
13.6
15
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
13.6
13
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
13.6
13
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
13.6
13
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
13.6
13
*
HAC20
NOMESCO Finland
Total mastectomy
141.6
13.5
14
*
A06AH03
ATC
naloxegol; oral
26.1
13.4
18
7
R50.9
ICD-10 Finland
Fever, unspecified
2.2
13.3
150
747
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
28.7
13.0
17
6
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
70.6
12.6
14
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
11.2
12.5
23
21
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.6
12.5
57
166
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
12.5
12
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
12.5
12
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
12.5
12
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
12.5
12
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
12.5
12
*
9670/3-C80.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site
+∞
12.5
12
*
L01CB01
ATC
etoposide; systemic
+∞
12.5
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
12.4
437
3181
JAH01
NOMESCO Finland
Laparoscopy
4.6
12.1
41
91
JFF10
NOMESCO Finland
Loop enterostomy
65.6
11.6
13
*
JAL30
NOMESCO Finland
Omentectomy
19.1
11.6
17
9
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
11.5
11
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
11.5
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
11.5
11
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
11.5
11
*
JFB30
NOMESCO Finland
Right hemicolectomy
13.8
11.5
19
14
WX402
NOMESCO Finland
General anaesthesia
2.3
11.5
108
494
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
121.2
11.4
12
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
121.2
11.4
12
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.1
11.3
35
71
JAH00
NOMESCO Finland
Laparotomy
3.9
11.3
45
118
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.2
11.1
26
37
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
14.0
11.0
18
13
N02AA01
ATC
morphine; systemic, rectal
7.3
10.8
25
35
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
6.4
10.6
27
43
L02AE03
ATC
goserelin; implant
60.6
10.6
12
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
111.0
10.4
11
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
111.0
10.4
11
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
10.4
10
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
10.4
10
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
10.4
10
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
+∞
10.4
10
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
10.4
10
*
D75
ICPC
Malignant neoplasm colon/rectum
+∞
10.4
10
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
10.4
10
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
10.4
10
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.8
10.2
33
71
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
10.1
10.0
19
19
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
10.0
37
91
A07AA02
ATC
nystatin; oral
2.5
9.9
76
314
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
5.5
9.8
28
52
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
26.3
9.8
13
5
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
10.7
9.8
18
17
L02BA01
ATC
tamoxifen; oral
55.5
9.7
11
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
55.5
9.7
11
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
9.6
69
277
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
100.8
9.4
10
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
100.8
9.4
10
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
100.8
9.4
10
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
30.3
9.4
12
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
9.4
9
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
9.4
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
9.4
9
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
9.4
9
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
C76.7
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Other ill-defined sites
+∞
9.4
9
*
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
+∞
9.4
9
*
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
9.4
9
*
WF099
NOMESCO Finland
Other radiotherapy
+∞
9.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
9.4
9
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
9.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
9.4
9
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.9
9.3
29
60
UJC02
NOMESCO Finland
Rigid oesophagoscopy
7.5
8.9
20
27
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
18.8
8.9
13
7
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
6.9
8.9
21
31
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
14.1
8.7
14
10
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
14.1
8.7
14
10
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
50.4
8.7
10
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
6.2
8.6
22
36
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.2
8.6
43
137
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.4
8.6
13
8
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
8.5
32
81
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
90.7
8.4
9
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
8.3
8
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
8.3
8
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
8.3
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
8.3
8
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
8.3
8
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
8.3
8
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
8.3
8
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
8.3
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
8.3
8
*
9590/3-C80.9
ICD-O-3
Malignant lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
+∞
8.3
8
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
8.3
8
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.6
8.3
200
2862
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
8.2
80
375
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
8.2
63
1210
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.1
8.1
42
138
UGC02
NOMESCO Finland
Rigid bronchoscopy
33.6
8.1
10
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
8.0
128
2010
M04AA01
ATC
allopurinol; systemic
1.7
7.9
188
1212
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
13.1
7.9
13
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
7.9
54
211
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
45.3
7.7
9
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.7
7.6
49
185
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
25.2
7.6
10
*
S77
ICPC
Malignant neoplasm of skin
25.2
7.6
10
*
K85
ICPC
Elevated blood pressure
0.5
7.5
52
1037
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
10.1
7.5
14
14
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
80.6
7.4
8
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
80.6
7.4
8
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
80.6
7.4
8
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
80.6
7.4
8
*
M05BA02
ATC
clodronic acid; systemic
80.6
7.4
8
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
7.7
7.4
16
21
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
13.5
7.4
12
9
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
+∞
7.3
7
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
7.3
7
*
G03HA01
ATC
cyproterone; systemic
+∞
7.3
7
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
7.3
7
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
7.3
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
L02BX02
ATC
degarelix; parenteral
+∞
7.3
7
*
T73
ICPC
Neoplasm endocrine other/unspecified
+∞
7.3
7
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
7.3
7
*
GDC00
NOMESCO Finland
Lobectomy of lung
+∞
7.3
7
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
7.3
7
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
7.3
7
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
7.3
7
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
7.3
7
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
7.3
7
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
7.3
7
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
7.3
7
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
9.4
7.3
14
15
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
15.9
7.2
11
7
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
30.2
7.2
9
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
30.2
7.2
9
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.4
7.0
32
739
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
10.1
7.0
13
13
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.9
7.0
41
146
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
7.0
41
147
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.2
6.9
20
39
A06AD11
ATC
lactulose; oral
1.6
6.9
211
1445
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.7
6.9
45
172
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
13.9
6.9
11
8
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.3
6.8
19
36
L13
ICPC
Hip symptom/complaint
0.5
6.8
54
1027
K83.1
ICD-10 Finland
Obstruction of bile duct
5.7
6.8
18
32
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.6
6.7
28
79
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
22.6
6.7
9
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
6.5
6.6
16
25
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
6.6
188
1264
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.9
6.6
25
65
D70.89
ICD-10 Finland
Neutropenic splenomegaly
8.7
6.6
13
15
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.2
6.5
23
56
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
6.5
57
1057
TGA30
NOMESCO Finland
Thoracocentesis
6.2
6.5
16
26
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
70.2
6.4
7
*
SPAT1053
SPAT
Memory test
0.6
6.4
93
1500
L08
ICPC
Shoulder symptom/complaint
0.5
6.3
62
1109
UKC02
NOMESCO Finland
Cystoscopy
1.6
6.3
170
1128
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
9.3
6.3
12
13
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.4
6.3
51
221
C10AA05
ATC
atorvastatin; oral
0.7
6.3
248
3257
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
6.3
6
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
6.3
6
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
6.3
6
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
6.3
6
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
6.3
6
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
6.3
6
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
+∞
6.3
6
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
6.3
6
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
6.3
6
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
B72
ICPC
Hodgkin Lymphoma
+∞
6.3
6
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
6.3
6
*
A04AA03
ATC
tropisetron; systemic
+∞
6.3
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.3
6
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
6.3
6
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
6.3
6
*
H29
ICPC
Ear symptom/complaint other
0.4
6.2
22
562
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
6.2
131
814
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.1
6.1
22
55
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.7
6.0
37
138
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
535
722
10.05
307.65
3.6
1.4
ug/l
64.3
3.7
4.22
445
543
(4035726)
431
319
17.36
307.65
1.5
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
250
252
11.32
224.46
2.8
1.8
u/ml
3077.4
120.5
1.79
212
199
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
151
138
11.83
143.70
3.1
1.7
u/ml
943.9
85.9
0.91
137
124
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
63
12
54.29
110.37
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
74
27
28.50
109.50
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
124
147
8.97
97.37
1.2
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
388
1312
3.48
92.87
5.7
2.7
u/l
302.8
239.0
3.03
369
1208
(40768441) Liver Pathology biopsy report
72
49
15.24
81.26
1.1
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
436
1840
2.80
69.23
4.5
2.3
mmol/l
0.8
0.8
8.54
408
1658
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
974
6065
2.29
65.04
12.6
3.6
umol/l
15.2
12.3
1.87
942
5637
(4281824)
60
56
11.03
55.84
1.3
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
250
938
2.93
48.24
2.1
1.8
g/l
0.2
0.2
2.33
225
839
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
839
11556
0.49
47.26
6.0
6.5
mmol/mol
41.6
41.2
0.65
721
10529
(3023368) Bacteria identified in Blood by Culture
649
3798
2.10
46.36
5.6
3.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
913
12166
0.50
45.27
4.2
5.3
mmol/l
2.6
2.6
0.04
769
10978
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
875
11811
0.50
44.92
3.9
4.7
mmol/l
4.5
4.5
0.28
756
10712
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
868
11684
0.51
42.99
3.9
4.6
mmol/l
1.4
1.4
3.62
742
10515
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
51
61
8.56
39.53
1.2
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
811
5453
1.87
36.46
7.8
3.6
g/l
31.7
34.9
35.53
773
4936
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
927
11994
0.54
36.30
4.6
4.9
mmol/l
6.2
6.1
0.98
798
10691
(40768804) Tissue Pathology biopsy report
579
3517
1.94
35.31
2.7
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
856
11281
0.54
34.77
3.6
4.2
mmol/l
1.4
1.3
2.17
722
10050
(3044640) Blood type and Crossmatch panel - Blood
571
3480
1.93
34.29
3.2
2.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
913
6452
1.83
34.27
17.9
5.9
e9/l
4.5
4.5
0.16
820
5498
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
93
231
4.18
33.90
1.5
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
611
3863
1.87
32.43
6.9
5.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
35
33
10.78
32.23
3.8
2.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
44
59
7.61
31.01
2.9
2.5
e9/l
1.1
1.0
0.24
28
32
(3023487) Leukocytes [#/volume] in Peritoneal fluid
34
36
9.60
28.86
1.2
2.4
e6/l
1057.2
381.9
2.87
26
29
(40758558) Short blood count panel - Blood
457
2721
1.90
28.64
14.2
4.6
—
—
—
0
0
(3002256) Pathology report gross observation
190
802
2.53
28.57
1.4
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
630
4155
1.79
28.30
7.4
2.1
mmol/l
2.4
2.4
0.18
578
3392
(3028308) Erythrocytes [#/volume] in Pleural fluid
66
145
4.68
28.11
1.3
1.5
e6/l
88276.8
65857.1
0.15
40
86
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
121
410
3.09
27.61
2.5
2.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
61
129
4.85
27.19
1.6
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
248
1214
2.20
26.52
3.9
2.2
umol/l
15.8
8.6
1.58
225
1042
(3033658) Prothrombin time (PT) actual/Normal
470
2885
1.84
26.48
5.9
3.4
%
81.8
83.0
0.49
462
2791
(3042936) Bacteria identified in Isolate by Culture
319
1724
2.03
26.29
2.1
2.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
67
159
4.33
25.92
1.3
1.5
e6/l
1414.2
1465.4
0.05
50
116
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
30
31
9.81
25.89
1.2
2.5
e6/l
16252.6
63087.6
0.37
19
18
(3012441) Differential panel - Pleural fluid
62
139
4.58
25.77
1.3
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
144
560
2.70
25.52
2.2
1.7
ug/l
1.3
1.7
0.38
132
471
(3022096) Basophils/100 leukocytes in Blood
742
5244
1.70
25.34
7.1
5.3
%
0.6
0.7
3.04
696
4790
(3019069) Monocytes/100 leukocytes in Blood
761
5417
1.69
25.28
7.7
5.6
%
9.1
8.8
0.93
717
4950
(3006504) Eosinophils/100 leukocytes in Blood
758
5395
1.69
25.16
7.2
5.3
%
2.4
2.9
7.40
712
4912
(21494815) CD4 cells/100 lymphocytes in Specimen
35
46
7.73
25.08
2.2
2.6
%
20.8
44.7
—
5
7
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
101
328
3.20
24.75
1.7
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
437
2671
1.83
24.74
2.8
2.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
44
7.85
24.68
2.1
2.9
%
13.4
15.1
0.20
11
18
(3002030) Lymphocytes/100 leukocytes in Blood
768
5517
1.67
24.39
7.5
5.5
%
22.7
26.0
9.69
720
5021
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
39
8.33
24.38
2.3
3.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
29
32
9.18
23.85
1.3
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
579
3879
1.72
23.74
3.2
2.2
u/l
51.2
59.1
4.00
539
3543
(3044007) Cell count panel - Peritoneal fluid
26
26
10.12
22.94
1.2
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
150
3151
0.43
22.47
1.6
1.6
mmol/l
1.6
1.3
2.78
123
2617
(3045142) Bone marrow Pathology biopsy report
45
87
5.27
22.23
1.4
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
59
144
4.20
22.03
3.5
3.1
%
2.8
1.5
0.90
48
101
(3032080) INR in Blood by Coagulation assay
761
5564
1.63
21.83
8.4
11.2
inr
1.2
1.4
4.55
207
1530
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
52
118
4.50
21.31
1.2
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1141
13326
0.61
20.92
41.8
21.4
g/l
123.2
133.9
81.97
1120
12989
(3026361) Erythrocytes [#/volume] in Blood
1141
13323
0.62
20.85
41.5
21.3
e12/l
4.1
4.4
55.14
1098
12747
(3035941) MCH [Entitic mass]
1141
13322
0.62
20.83
41.3
21.2
pg
30.2
30.4
4.75
1119
12981
(3020630) Protein [Mass/volume] in Serum or Plasma
220
1125
2.08
20.82
3.1
1.5
g/l
64.3
66.6
3.23
199
982
(3024731) MCV [Entitic volume]
1141
13321
0.62
20.80
41.4
21.2
fl
91.4
91.7
1.06
1119
12979
(3010813) Leukocytes [#/volume] in Blood
1142
13329
0.62
20.78
41.5
21.3
e9/l
7.4
6.9
5.94
1099
12754
(3007461) Platelets [#/volume] in Blood
1141
13320
0.62
20.78
41.5
21.2
e9/l
253.6
241.7
4.21
1108
12802
(3042111) Morphology [Interpretation] in Bone marrow Narrative
63
172
3.75
20.19
1.3
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
548
3753
1.66
20.02
5.5
3.1
ph
7.4
7.4
0.42
129
651
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
77
243
3.26
19.79
1.8
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
115
454
2.63
19.76
2.2
2.6
u/ml
0.4
0.4
0.28
65
273
(3042631) Mycobacterium sp identified in Specimen
60
161
3.82
19.71
2.3
2.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
778
5826
1.58
19.55
7.0
4.9
mmol/l
1.2
1.2
0.03
724
5109
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
61
168
3.72
19.31
1.9
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
775
5811
1.58
19.29
7.0
5.1
e9/l
0.0
0.0
0.66
675
4917
(3019198) Lymphocytes [#/volume] in Blood
786
5916
1.57
19.22
7.1
5.2
e9/l
1.6
1.8
2.38
696
5094
(3001604) Monocytes [#/volume] in Blood
771
5778
1.58
19.21
7.0
5.1
e9/l
0.7
0.6
2.55
671
4876
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
918
11165
0.64
18.91
5.0
4.6
mu/l
5.3
2.1
0.52
807
9962
(21494814) CD8 cells/100 lymphocytes in Specimen
22
23
9.66
18.77
2.0
3.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
734
5461
1.57
18.74
7.2
5.3
%
61.2
58.9
4.81
690
4998
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
53
135
4.01
18.72
5.2
5.6
iu/ml
1420.0
503.4
—
9
17
(3013115) Eosinophils [#/volume] in Blood
792
5999
1.56
18.67
7.4
5.3
e9/l
0.2
0.2
5.42
695
5153
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
700
5166
1.57
18.43
5.0
3.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
30
47
6.47
18.37
3.6
1.5
e6/l
440.7
870.2
1.67
13
21
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
72
229
3.23
18.29
1.8
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
19
17
11.27
17.98
1.3
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
118
497
2.47
17.73
1.4
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
177
885
2.11
17.70
1.7
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
193
998
2.04
17.63
3.1
2.2
u/l
37.0
89.2
0.52
166
813
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
18
10.65
17.32
2.3
4.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
28
44
6.44
17.10
3.1
1.7
e6/l
524.8
425.0
0.51
23
38
(3045788) Cell count panel - Pleural fluid
49
127
3.93
16.92
1.3
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
70
5.07
16.68
1.4
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
384
2525
1.66
15.92
6.7
2.3
mmol/l
2.5
2.5
12.15
352
2133
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
171
3.41
15.91
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
162
817
2.08
15.81
1.5
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
821
6448
1.49
15.35
8.3
5.2
mmol/l
1.2
1.2
0.31
659
5363
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
27
7.85
15.28
2.6
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
27
7.85
15.28
2.6
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
27
7.85
15.28
2.7
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
72
256
2.88
15.13
2.1
2.4
umol/l
39.0
34.1
0.74
53
217
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1119
12831
0.67
14.83
18.8
9.1
u/l
28.1
24.9
4.00
1082
12169
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
22
31
7.16
14.82
1.3
1.2
ug/l
161.9
63.9
0.46
13
15
(3023103) Potassium [Moles/volume] in Serum or Plasma
1129
12913
0.67
14.65
31.6
18.0
mmol/l
4.0
4.0
1.19
1106
12462
(3003458) Phosphate [Moles/volume] in Serum or Plasma
272
1671
1.74
14.42
5.1
4.3
mmol/l
1.1
1.0
0.75
249
1503
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
486
3456
1.55
14.33
4.5
2.5
u/l
65.8
34.7
1.16
462
3266
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
138
3.54
14.32
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
60
199
3.08
14.26
3.3
3.1
%
58.7
59.9
0.21
60
199
(3019550) Sodium [Moles/volume] in Serum or Plasma
1129
12887
0.67
14.18
31.4
17.9
mmol/l
138.3
139.7
35.30
1108
12455
(40761511) CBC panel - Blood by Automated count
1078
12409
0.68
14.09
25.3
14.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
46
131
3.57
13.92
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
43
117
3.74
13.91
1.5
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
30
62
4.90
13.79
1.1
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
164
874
1.96
13.71
1.4
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
141
724
2.02
13.09
3.3
2.2
g/l
10.3
11.0
0.83
131
651
(3028026) IgM [Mass/volume] in Serum or Plasma
121
588
2.13
13.01
2.3
1.4
g/l
1.5
1.2
0.51
109
529
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
16
18
8.95
12.88
2.2
2.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
823
9877
0.70
12.80
37.3
19.4
g/l
329.6
331.6
7.37
812
9737
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
964
11223
0.70
12.39
28.7
13.6
ml/min/173m2
75.4
72.8
3.27
850
8996
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
64
4.58
12.35
1.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
28
60
4.72
12.35
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
48
153
3.19
12.22
1.4
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
69
269
2.62
12.22
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
184
1058
1.82
12.16
1.5
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
195
1146
1.78
11.98
6.6
5.4
mmol/l
10.4
11.6
1.29
185
1066
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
23
43
5.40
11.82
2.5
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
23
43
5.40
11.82
2.5
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
23
43
5.40
11.82
2.5
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
23
43
5.40
11.82
2.5
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
10
12.06
11.73
1.8
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
103
3.64
11.62
2.9
2.4
u/ml
106997.0
422.2
—
5
13
(3017181) Myelocytes/100 leukocytes in Blood
161
902
1.86
11.56
4.3
3.6
%
1.1
0.8
0.94
85
208
(3012501) Base excess in Blood by calculation
71
290
2.50
11.45
2.9
4.4
mmol/l
3.4
2.8
0.75
50
192
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
52
4.86
11.42
1.5
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
474
3496
1.48
11.34
3.3
3.1
e6/l
0.8
0.5
1.54
380
2673
(36304419) Bacteria [Presence] in Urine
459
3372
1.48
11.18
3.2
3.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
53
4.76
11.18
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
517
3889
1.46
11.15
3.6
3.1
e6/l
112.3
93.3
0.23
422
3016
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
90
421
2.19
10.68
1.4
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
455
5944
0.69
10.60
2.6
2.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
32
86
3.77
10.58
1.7
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
44
147
3.04
10.40
1.5
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
21
7.19
10.13
4.0
1.4
—
—
—
0
0
(3010421) pH of Blood
76
341
2.28
9.99
3.1
4.2
ph
7.4
7.4
0.05
70
284
(3026782) Osmolality of Urine
360
2570
1.50
9.97
3.2
2.6
mosm/kgh2o
524.9
544.6
1.07
321
2154
(40768800) Prostate Pathology biopsy report
29
76
3.86
9.94
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
32
91
3.56
9.77
1.6
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
19
7.41
9.69
1.1
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
11
10.05
9.54
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
33
5.49
9.44
1.4
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
167
1016
1.71
9.07
5.9
2.8
mmol/l
1.2
1.2
0.57
155
841
(40760892) CBC W Ordered Manual Differential panel - Blood
324
2309
1.49
8.98
5.5
4.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
243
3490
0.65
8.88
2.9
3.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
293
4042
0.67
8.76
4.0
3.8
%
21.5
24.4
2.52
155
1997
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
329
2373
1.47
8.55
2.0
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
780
9128
0.74
8.54
4.3
3.7
pmol/l
15.2
15.1
0.97
678
8124
(3009508) Creatinine [Moles/volume] in Urine
312
4232
0.68
8.49
2.8
3.1
mmol/l
7.4
7.2
0.29
242
3516
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1069
9361
1.34
8.36
15.5
5.2
u/l
115.3
77.9
16.72
1037
8570
(3020682) Albumin/Creatinine [Ratio] in Urine
328
4397
0.69
8.35
3.7
3.9
mg/mmol
9.5
8.6
0.17
198
2785
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
82
411
2.04
8.21
3.1
1.5
ratio
27.2
1.5
—
5
37
(40760888) Immunoglobulin light chains.free panel - Serum
68
317
2.19
8.20
3.0
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
306
4143
0.69
8.20
3.0
3.2
mg/l
1306.3
181.1
1.76
189
2625
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
9
14.52
8.20
6.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
71
339
2.14
8.07
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
71
339
2.14
8.07
1.3
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
367
2750
1.42
7.71
2.8
2.5
e6/l
5.6
5.5
0.03
335
2391
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
137
834
1.69
7.44
1.5
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
141
866
1.68
7.41
4.4
3.7
%
0.2
0.1
0.91
75
191
(1616796) Gas panel - Central venous blood
62
291
2.17
7.39
2.8
3.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
82
428
1.96
7.36
3.1
1.5
mg/l
28.1
50.5
1.01
63
341
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
50
4.03
7.34
2.1
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
115
2.90
7.32
4.8
3.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
82
429
1.95
7.31
3.1
1.5
mg/l
59.3
49.2
0.31
63
341
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
0
+∞
7.29
1.0
0.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
84
3.24
7.24
2.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
84
3.24
7.24
2.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
84
3.24
7.24
2.3
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
80
3.28
7.10
1.4
1.5
u/l
21.3
4120.4
—
8
23
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
30
101
3.00
7.08
2.3
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
147
2.62
6.96
1.4
1.3
u/l
18.1
9.9
1.78
31
120
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
39
4.39
6.95
5.2
1.1
u/ml
152.5
37.1
—
6
10
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
92
3.07
6.89
2.4
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
762
8779
0.77
6.67
4.4
4.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
236
1673
1.47
6.63
2.8
2.0
%
1.8
1.8
0.24
201
1448
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
270
1969
1.43
6.53
3.2
2.9
e6/l
3.0
2.5
0.39
160
1087
(3018095) Leukocytes [#/volume] in Urine
549
4485
1.32
6.52
4.3
3.6
e6/l
233.1
111.7
0.54
434
3232
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
25
5.23
6.48
1.1
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
18
6.14
6.42
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
488
5942
0.76
6.42
1.9
2.1
pmol/l
92.1
92.5
0.06
261
3008
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
51
235
2.20
6.40
1.6
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
7
14.34
6.39
1.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
56
3.60
6.31
2.5
2.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
398
4973
0.74
6.24
4.6
3.9
ug/l
3.5
2.3
0.91
348
4406
(3009542) Hematocrit [Volume Fraction] of Blood
941
10487
0.79
5.95
27.9
16.2
%
36.1
38.7
9.65
591
6517
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
54
3.54
5.88
1.3
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
155
2.41
5.80
1.2
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
263
3464
0.72
5.74
1.5
1.6
nmol/l
18.8
20.2
0.80
229
2897
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
104
633
1.68
5.70
1.6
1.5
g/l
2.0
1.5
2.69
80
527
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
191
1343
1.47
5.59
4.7
3.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
204
2784
0.70
5.47
2.9
2.7
ug/l
0.7
0.8
0.39
151
1926
(40761536) Microorganisms panel - Urine sediment
143
953
1.54
5.42
4.3
4.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
39
173
2.28
5.40
1.6
1.9
%
88.4
89.7
0.37
39
173
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
603
0.39
5.36
2.2
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
148
998
1.52
5.32
4.3
1.8
nmol/l
384.2
374.1
0.23
140
891
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
237
1751
1.40
5.31
2.3
2.5
%
19.6
22.2
2.27
209
1452
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
33
138
2.41
5.22
1.1
1.3
u/ml
100.9
114.0
—
8
24
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
226
1665
1.41
5.15
1.8
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
250
1880
1.38
5.04
2.1
2.3
g/l
2.1
2.3
2.94
226
1712
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
55
290
1.92
4.89
1.8
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
54
285
1.92
4.80
2.2
2.4
%
15.2
16.2
0.67
19
144
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1123
12140
0.80
4.79
30.0
14.7
mg/l
39.2
25.9
23.13
1052
9706
(3003396) Base excess in Arterial blood by calculation
210
1554
1.40
4.67
5.5
5.8
mmol/l
1.5
1.3
0.30
167
1179
(3014111) Lactate [Moles/volume] in Serum or Plasma
163
1154
1.45
4.63
4.2
5.2
mmol/l
1.5
1.5
0.07
154
1096
(3004588) Protein electrophoresis panel - Serum or Plasma
143
987
1.49
4.62
2.6
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
122
1771
0.67
4.53
1.2
1.3
u/ml
34.0
14.4
0.85
40
657
(3022948) Iron [Moles/volume] in Serum or Plasma
266
2056
1.34
4.50
2.2
2.3
umol/l
10.4
12.5
5.02
244
1856
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
68
1120
0.59
4.42
1.4
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
209
1562
1.38
4.38
5.6
5.8
kpa
5.1
5.1
0.05
203
1475
(3027801) Oxygen [Partial pressure] in Arterial blood
209
1562
1.38
4.38
5.6
5.8
kpa
12.6
11.3
2.75
203
1474
(3048929) Epstein Barr virus Ab [Presence] in Serum
41
205
2.02
4.27
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
220
1665
1.36
4.27
1.8
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
121
823
1.50
4.22
4.4
3.6
%
1.0
0.6
0.86
48
159
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
129
1827
0.68
4.22
11.5
7.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
75
456
1.67
4.21
1.7
1.9
u/l
37.6
38.8
0.21
64
385
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
398
0.35
4.16
1.6
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
47
250
1.90
4.12
1.2
1.3
mmol/l
55.1
63.5
0.75
36
194
(3023520) Reticulocytes [#/volume] in Blood
167
1215
1.41
4.11
2.7
2.2
e9/l
66.5
67.8
0.18
118
943
(3019060) Gas panel - Arterial blood
136
953
1.46
4.10
4.4
4.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
64
376
1.73
4.08
3.4
3.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
40
203
1.99
4.02
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
168
2252
0.72
4.01
1.2
1.2
u/ml
1.2
1.9
0.55
40
586
(3025159) Blasts/100 leukocytes in Blood
119
817
1.49
3.98
4.6
3.8
%
0.2
0.6
0.33
57
169
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
150
2.15
3.96
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
821
0.56
3.84
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
872
9563
0.83
3.80
35.0
17.5
%
14.7
13.8
36.99
857
9257
(3051651) Icteric interference index of Serum or Plasma
15
49
3.08
3.80
2.9
3.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
267
2115
1.31
3.80
2.9
2.7
e6/l
2.0
1.4
0.71
158
1225
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
140
2.16
3.77
1.1
1.1
u/ml
310.9
278.7
0.26
21
76
(3000991) Gas panel - Venous blood
147
1064
1.41
3.74
5.3
6.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
32
154
2.10
3.72
6.6
6.1
mg/l
11.6
12.6
0.75
32
138
(3021589) Normoblasts [#/volume] in Blood
580
5051
1.22
3.61
15.1
8.7
e9/l
0.0
0.0
0.60
470
4064
(40768797) Stomach Pathology biopsy report
209
1613
1.33
3.58
1.2
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
838
7563
1.20
3.56
5.9
4.2
mmol/l
7.0
6.9
0.47
811
7067
(3003694) ABO and Rh group [Type] in Blood
328
2698
1.26
3.46
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
52
304
1.73
3.42
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
88
589
1.52
3.37
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
42
233
1.82
3.30
1.1
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
86
577
1.51
3.26
2.5
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
30
149
2.03
3.25
1.2
1.2
iu/l
36.4
30.2
0.40
25
131
(3024869) Neuronal Ab [Presence] in Serum
9
19
4.75
3.23
1.6
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
92
632
1.48
3.13
3.6
3.2
mmol/l
23.6
24.1
0.69
85
551
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
61
2.63
3.13
3.9
2.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
443
5098
0.83
3.06
2.2
2.2
nmol/l
75.5
79.0
1.86
388
4377
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
8
7.51
3.05
2.7
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
13
45
2.90
3.02
1.8
1.2
nmol/l
0.1
0.3
—
8
37
(21494890) Protein electrophoresis panel - 24 hour Urine
24
113
2.14
3.00
2.9
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
40
3.01
2.97
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
51
311
1.66
2.92
1.3
1.5
ug/g
231.4
286.8
1.08
32
189
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
263
3175
0.80
2.88
1.7
1.7
pmol/l
473.0
24464776.3
2.42
203
2567
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
9
6.68
2.86
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
24
116
2.08
2.82
2.4
2.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
42
246
1.72
2.80
1.2
1.2
e6/l
32.0
39.1
0.09
36
208
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
42
246
1.72
2.80
1.3
1.3
e6/l
356.9
639.6
0.26
36
213
(4094501)
14
326
0.42
2.75
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
27
138
1.97
2.75
1.1
1.0
—
—
—
0
0
(4034850)
25
472
0.52
2.73
19.8
10.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
14
5.01
2.72
1.0
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
10
6.01
2.69
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
842
9107
0.86
2.68
4.6
4.1
mm/h
23.0
13.7
21.40
752
8302
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
9
24
3.76
2.67
1.3
1.0
%
113.2
95.1
—
9
18
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
10
32
3.13
2.64
1.4
1.3
%
14.8
23.5
—
10
26
(4062490)
20
93
2.16
2.60
1.4
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
299
2512
1.23
2.60
1.7
1.6
mg/l
2.2
1.4
2.85
235
1961
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
142
1.91
2.55
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
117
874
1.36
2.54
4.2
3.3
ph
7.4
7.4
0.05
16
107
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
378
4342
0.84
2.50
2.4
2.2
u/l
203.0
237.9
0.38
355
4037
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
92
663
1.41
2.49
5.7
7.2
mmol/l
24.3
24.3
0.01
86
589
(3002032) Base excess in Venous blood by calculation
169
1336
1.29
2.49
3.7
3.0
mmol/l
2.0
2.0
0.08
125
1044
(3031040) Bacteria [#/volume] in Urine by Automated count
910
8433
1.16
2.46
5.5
4.8
e6/l
1786.6
3292.7
0.36
25
162
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
118
890
1.35
2.43
4.2
3.3
kpa
5.1
5.2
0.20
111
813
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
128
1653
0.76
2.42
4.1
4.8
%
33.6
33.3
0.09
82
1061
(3016018) Differential panel - Cerebral spinal fluid
19
90
2.12
2.38
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
104
2.03
2.36
3.5
3.1
%
58.1
57.0
—
9
67
(3007853) Bacteria identified in Skin by Aerobe culture
177
1418
1.27
2.36
1.9
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
144
1822
0.77
2.34
1.2
1.3
iu/ml
50.0
38.9
0.28
46
572
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
112
844
1.35
2.33
4.3
3.3
mmol/l
1.9
2.0
0.11
91
605
(3014007) Fractional oxyhemoglobin in Arterial blood
105
785
1.36
2.30
6.4
7.4
%
93.8
93.3
0.26
105
780
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
41
254
1.63
2.27
1.2
1.2
mmol/l
3.8
3.9
0.26
36
234
(21494434) Karyotype in Bone marrow
20
99
2.03
2.25
1.1
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
93
2.05
2.21
1.4
1.4
g/l
3.8
2.9
0.48
12
67
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
93
2.05
2.21
1.4
1.4
g/l
0.5
0.4
0.41
13
67
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
93
2.05
2.21
1.4
1.4
g/l
5.6
7.0
1.10
13
68
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
104
782
1.35
2.20
6.4
7.3
%
0.7
0.7
0.31
104
777
(44806118)
22
114
1.94
2.20
1.2
1.5
—
—
—
0
0
(44790049)
22
114
1.94
2.20
1.2
1.5
—
—
—
0
0
(44790048)
22
114
1.94
2.20
1.2
1.5
—
—
—
0
0
(44790047)
22
114
1.94
2.20
1.2
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
384
3360
1.18
2.16
3.8
2.5
umol/l
3497.2
7513.5
1.26
335
2828
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
21
108
1.95
2.15
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
74
2.17
2.14
1.6
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
260
3049
0.83
2.14
4.2
3.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
64
445
1.45
2.14
3.0
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
75
539
1.41
2.10
2.0
1.7
—
—
—
0
0
(1002224) Polysomnography panel
17
330
0.51
2.09
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
110
1.92
2.05
2.9
3.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
559
1.39
2.04
3.1
1.4
g/l
3.6
3.9
0.89
52
385
(3000494) Fungus identified in Specimen by Culture
158
1273
1.26
2.04
1.5
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
15
4.01
2.04
2.5
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
560
1.39
2.03
3.1
1.4
g/l
8.0
7.6
0.94
52
399
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
560
1.39
2.03
3.1
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
166
1347
1.25
2.02
3.7
3.0
kpa
5.7
5.8
0.57
160
1291
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
55
379
1.46
1.95
3.1
1.4
g/l
0.0
0.0
0.00
46
344
(3026389) Candida sp identified in Specimen by Organism specific culture
26
149
1.75
1.94
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
33
2.73
1.93
1.6
1.0
—
—
—
0
0
(4010399)
63
869
0.71
1.89
1.5
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
397
3522
1.16
1.87
2.1
2.3
mg/l
3.5
3.1
2.27
324
2952
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
28
2.86
1.86
3.9
2.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
519
1.38
1.84
3.2
1.4
g/l
3.6
3.1
1.76
53
393
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
55
384
1.44
1.84
3.1
1.4
g/l
0.0
0.0
0.00
46
345
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
17
3.53
1.83
1.2
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
426
1.42
1.83
7.0
2.4
g/l
0.2
0.3
2.07
35
133
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
53
2.27
1.80
1.6
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
53
2.27
1.80
1.6
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
73
2.06
1.80
1.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
73
2.06
1.80
1.6
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
746
0.70
1.80
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
47
2.35
1.77
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
139
1.73
1.75
1.9
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
36
2.50
1.73
2.8
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
54
2.23
1.73
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
57
406
1.42
1.73
3.0
1.4
g/l
0.0
0.0
0.66
48
366
(3005988) Vibrio sp identified in Specimen by Organism specific culture
24
140
1.72
1.71
1.9
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
526
1.36
1.71
2.6
1.4
g/l
10.5
10.6
0.04
58
430
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
48
2.30
1.70
3.3
2.7
u/ml
3162.2
1143.7
0.70
11
48
(3019309) Folate [Moles/volume] in Red Blood Cells
280
3197
0.85
1.70
2.0
1.8
nmol/l
1278.2
1170.5
1.01
201
2390
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
89
1.92
1.69
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
141
1.71
1.68
1.9
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
80
608
1.33
1.65
1.8
2.1
nmol/l
9.9
14.7
4.85
67
530
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
24
142
1.70
1.64
1.9
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
24
142
1.70
1.64
1.9
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
37
248
1.50
1.55
1.8
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
159
0.44
1.54
1.9
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
52
374
1.40
1.52
2.5
3.0
mmol/l
25.2
25.0
0.08
46
331
(3023410) Appearance of Cerebral spinal fluid
18
101
1.79
1.48
1.3
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
38
544
0.69
1.46
1.4
1.4
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
99
790
1.27
1.45
6.3
7.3
%
1.3
1.4
0.25
99
784
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
62
464
1.35
1.44
2.9
1.4
g/l
1.7
0.5
1.46
50
386
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
35
236
1.49
1.44
1.5
1.7
iu/l
2.8
4.4
—
10
78
(3048689) Calprotectin [Mass/mass] in Stool
93
1161
0.79
1.43
2.0
2.1
ug/g
209.3
166.9
0.28
72
902
(3024932) HLA-DR beta [Type]
6
22
2.73
1.43
1.5
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
22
2.73
1.43
1.3
1.0
—
—
—
0
0
(4015189)
9
39
2.31
1.43
2.0
2.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
39
2.31
1.43
1.1
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
258
2922
0.86
1.42
4.9
4.3
kg/l
1.0
1.0
0.22
54
435
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
141
1.64
1.41
2.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
54
397
1.37
1.41
4.8
4.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
17
96
1.78
1.38
1.1
1.2
u/l
77.7
52.5
0.49
11
66
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
17
2.94
1.36
1.6
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
59
445
1.34
1.32
2.9
1.4
g/l
35.7
37.1
0.75
50
359
(3030981) Hyaline casts [#/volume] in Urine by Automated count
90
719
1.26
1.32
3.7
2.5
e6/l
0.4
0.3
0.27
90
700
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
129
1.63
1.29
1.4
1.2
nmol/l
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
34
2.36
1.29
1.6
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
305
0.62
1.28
2.1
2.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
18
2.78
1.28
1.2
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
80
634
1.27
1.27
6.4
8.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
92
1.74
1.24
1.0
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
36
2.23
1.24
2.0
1.9
nmol/l
4.1
16.1
—
8
27
(3037522) Nuclear Ab [Titer] in Serum
120
1428
0.83
1.21
1.3
1.3
titre
362.5
593.9
2.38
32
346
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
26
173
1.51
1.17
1.3
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
94
1.71
1.17
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
463
4279
1.11
1.14
3.6
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
111
1.63
1.12
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
136
1.55
1.08
1.5
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
26
177
1.47
1.07
1.4
2.4
mg/l
44.0
22.0
—
6
33
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
371
0.70
1.05
1.5
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
79
644
1.24
1.03
5.1
3.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
23
334
0.68
1.02
1.9
1.6
e6/l
10763.2
14393.5
0.23
16
250
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
196
1.43
1.02
3.8
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
460
0.73
1.01
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
127
1087
1.18
1.01
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
248
2229
1.13
1.01
22.8
30.1
inr
1.4
1.5
0.22
30
293
(4024509)
7
135
0.52
0.98
1.1
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
22
149
1.48
0.95
1.5
1.2
nmol/l
0.6
0.7
0.25
22
141
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
51
1.77
0.94
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
51
1.77
0.94
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
544
0.77
0.94
1.8
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
279
0.68
0.91
1.6
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
255
0.66
0.91
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
41
315
1.31
0.88
2.1
2.2
g/l
117.9
130.8
2.39
29
237
(3021601) Nitrite [Presence] in Urine by Test strip
579
6107
0.92
0.88
6.2
5.2
estimate
0.0
0.0
0.00
141
1036
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
192
0.62
0.86
1.2
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
587
6184
0.92
0.86
4.6
3.9
estimate
0.0
0.0
1.08
141
1013
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
11
64
1.72
0.86
1.4
1.5
u/l
8.6
8.5
—
5
31
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
145
1.45
0.84
1.4
1.8
g/l
0.7
1.1
0.52
15
113
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
165
0.60
0.82
2.1
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
63
517
1.23
0.81
2.0
2.2
ug/l
203.6
854.1
1.00
58
484
(3004451) EKG impression Narrative
12
73
1.65
0.81
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
106
914
1.17
0.81
1.8
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
89
1.58
0.81
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
580
6097
0.93
0.80
4.5
3.8
estimate
0.0
0.0
0.00
145
1046
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
58
1.73
0.79
2.2
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
58
1.73
0.79
2.2
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
547
1.21
0.78
3.4
2.9
pmol/l
4.2
4.4
1.22
58
465
(3044941) Cell count panel - Synovial fluid
15
222
0.67
0.77
1.3
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
77
907
0.84
0.77
3.4
3.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
34
1.77
0.76
1.5
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
28
0.00
0.76
0.0
2.4
—
2.7
—
0
10
(3036071) Salmonella sp Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
34
437
0.77
0.76
1.1
1.1
—
158.2
—
0
13
(3019225) pH of Specimen
149
1326
1.13
0.75
5.7
3.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
52
423
1.23
0.74
5.6
5.3
mmol/l
1.3
1.3
0.20
47
372
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
401
0.77
0.73
1.5
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
288
0.73
0.73
2.8
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
467
4933
0.93
0.73
2.8
2.7
ug/l
313.4
139.4
5.86
418
4458
(3000492) Spirometry study
82
955
0.85
0.72
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(4133840)
5
26
1.92
0.70
3.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
31
239
1.30
0.69
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
451
0.79
0.67
1.4
1.8
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
17
237
0.71
0.66
1.8
1.8
nmol/l
38.4
44.5
0.76
17
226
(3007566) Smooth muscle Ab [Titer] in Serum
35
277
1.27
0.65
1.1
1.1
titre
82.0
80.4
—
5
23
(3023419) Bacteria identified in Sputum by Culture
24
180
1.34
0.64
1.5
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
128
0.62
0.64
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
129
0.62
0.64
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
130
0.61
0.63
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
130
0.61
0.63
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
188
0.69
0.62
1.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
30
1.67
0.61
1.4
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
152
0.66
0.61
1.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
21
0.00
0.60
0.0
2.9
—
0.4
—
0
21
(3021788) Differential panel - Synovial fluid
18
243
0.74
0.59
2.3
1.5
—
—
—
0
0
(44806420)
8
52
1.54
0.59
2.3
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
34
272
1.25
0.59
2.4
2.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
61
521
1.18
0.57
4.9
3.9
mmol/l
1.7
1.5
0.30
61
508
(3034274) Bile acid [Moles/volume] in Serum --fasting
8
54
1.48
0.57
1.3
1.2
umol/l
5.3
9.4
—
8
29
(3017704) Immunofixation for Urine
12
81
1.48
0.57
1.1
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
89
0.56
0.56
1.8
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
86
758
1.14
0.54
4.1
3.0
e9/l
4.1
4.2
0.10
60
520
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
39
1.54
0.53
1.3
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
31
381
0.81
0.52
2.5
2.2
ug/min
121.3
96.4
0.12
20
228
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
26
326
0.79
0.52
1.2
1.4
—
18.3
—
0
8
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
97
0.62
0.52
1.2
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
40
1.50
0.51
1.5
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
133
1456
0.91
0.50
2.8
3.2
ng/l
260.2
278.6
0.12
123
1332
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
103
1143
0.89
0.50
1.4
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
124
1128
1.11
0.48
3.5
2.6
kpa
4.3
4.4
0.55
118
1074
(3023420) DNA double strand Ab [Units/volume] in Serum
7
110
0.63
0.48
1.0
1.3
—
33.2
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
48
1.46
0.46
1.6
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
66
748
0.88
0.46
4.9
3.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
40
471
0.85
0.46
1.4
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
119
0.67
0.45
1.3
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
17
129
1.32
0.45
1.2
1.2
—
76.1
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
361
0.83
0.43
1.9
1.9
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
31
1.61
0.43
2.6
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
212
1.23
0.42
1.5
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
10
70
1.43
0.41
1.1
1.2
mmol/l
14.1
11.6
—
5
23
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
11
79
1.39
0.40
1.1
1.7
umol/l
15.0
14.1
0.11
11
70
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
54
613
0.88
0.40
1.2
1.3
—
46.7
—
0
26
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
26
214
1.22
0.39
1.2
1.2
u/ml
57.0
47.7
—
5
24
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
71
1.41
0.39
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
2.0
2.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
37
1.35
0.37
1.2
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
34
290
1.17
0.36
1.1
1.1
—
1837.0
—
0
10
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
223
0.80
0.36
1.5
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
42
1.43
0.35
1.2
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
10
134
0.74
0.35
5.0
2.4
u/field
1.2
2.0
—
5
46
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
208
1.20
0.35
2.1
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
202
1909
1.06
0.35
1.6
1.3
g/l
2.4
2.7
1.58
147
1076
(3016244) Insulin [Units/volume] in Serum or Plasma
6
44
1.36
0.34
3.7
3.6
mu/l
16.1
24.8
—
6
38
(3041096) Erythrocytes [Presence] in Urine by Automated
327
3136
1.05
0.34
4.6
3.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
467
0.87
0.34
1.2
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
89
0.67
0.33
1.3
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
43
379
1.14
0.32
1.3
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
129
1.24
0.30
1.3
1.3
—
—
—
0
0
(4027681)
7
56
1.25
0.29
1.6
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
82
887
0.92
0.29
4.0
2.8
g/l
120.6
128.5
2.95
82
868
(44813793)
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
13
103
1.26
0.28
1.0
1.1
mmol/l
29.0
34.2
0.49
13
89
(3044927) Protein electrophoresis panel - Urine
15
183
0.82
0.27
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
54
594
0.91
0.27
1.2
1.2
u/ml
226.4
234.7
0.03
46
541
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
104
1.25
0.26
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
77
1.30
0.26
1.3
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
244
1.15
0.25
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
9
73
1.23
0.25
1.3
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
371
0.89
0.24
1.8
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
39
351
1.11
0.23
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
464
4746
0.97
0.23
4.9
4.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
153
1.18
0.22
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
64
593
1.08
0.22
5.4
4.4
—
—
—
0
0
(4146454)
13
156
0.83
0.21
1.9
2.7
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
11
0.00
0.21
0.0
1.7
—
23.3
—
0
6
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
465
4750
0.97
0.21
3.3
3.1
ng/l
2221.6
1902.6
0.65
404
4095
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
481
0.91
0.21
1.2
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
39
354
1.10
0.20
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
123
0.81
0.20
1.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
51
1.18
0.19
1.8
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
52
1.15
0.19
1.2
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
90
1.22
0.19
2.9
2.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
29
261
1.11
0.18
1.2
1.2
—
473.3
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
32
290
1.10
0.18
1.6
1.7
—
—
—
0
0
(3013512) EKG study
394
4019
0.97
0.17
4.4
4.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
66
0.76
0.17
1.4
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
69
0.72
0.17
6.0
3.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
129
1.16
0.16
1.5
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
69
1.16
0.16
4.0
3.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(4211845)
6
76
0.79
0.15
5.2
3.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
76
0.79
0.15
1.2
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
6
78
0.77
0.15
1.7
1.7
—
15.4
—
0
7
(3000034) Microalbumin [Mass/volume] in Urine
15
130
1.15
0.15
3.9
3.2
mg/l
41.8
34.6
—
10
100
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
38
351
1.08
0.15
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
84
1.19
0.13
1.5
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
96
0.83
0.13
2.3
1.8
%
8.2
10.2
—
8
96
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
96
996
0.96
0.12
6.0
2.4
ml/min/173m2
60.2
62.0
0.22
38
421
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
137
0.87
0.12
1.6
1.8
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
36
336
1.07
0.12
4.9
3.1
mmol/l
6.9
7.8
1.43
36
328
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
120
1238
0.97
0.12
1.2
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
86
1.16
0.10
1.4
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
122
1184
1.03
0.10
3.7
3.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
51
535
0.95
0.10
1.3
1.5
—
24.6
—
0
17
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
28
300
0.93
0.10
1.3
1.2
u/ml
17.6
3.4
—
5
52
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
566
5596
1.02
0.10
4.5
4.2
ng/l
43.9
111.5
1.23
471
4245
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
47
1.06
0.09
1.6
1.0
—
—
—
0
0
(4306422)
11
124
0.89
0.09
1.0
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.5
1.9
nmol/l
18.5
18.0
—
6
43
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
58
1.03
0.08
1.0
1.3
nmol/l
162.7
144.0
—
6
58
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
164
0.91
0.08
1.7
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
71
0.84
0.07
2.5
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
28
296
0.94
0.07
1.3
1.2
u/ml
4.9
2.7
—
5
28
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
8
78
1.02
0.07
1.5
2.1
—
179.0
—
0
22
(3035320) C reactive protein [Mass/volume] in Body fluid
7
82
0.85
0.07
2.0
2.4
—
—
—
0
0
(4268621)
9
85
1.06
0.07
2.2
2.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
92
0.87
0.06
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
712
7070
1.01
0.06
4.1
2.9
u/l
104.8
50.4
9.50
663
6385
(3051593) INR in Capillary blood by Coagulation assay
8
94
0.85
0.06
13.4
15.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
167
1.08
0.06
1.3
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
68
697
0.97
0.05
5.0
3.4
%
45.8
47.7
0.29
68
688
(3037467) Urinalysis macro (dipstick) panel - Urine
870
8655
1.01
0.05
5.4
4.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
42
405
1.04
0.05
1.1
1.2
u/ml
0.3
0.5
—
5
39
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
58
564
1.03
0.05
1.3
1.2
iu/ml
41.9
132.3
5.05
20
219
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
11
120
0.92
0.05
1.0
1.1
%
122.5
116.1
0.31
11
108
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
411
0.97
0.03
2.3
3.2
nmol/l
0.9
0.8
0.29
24
314
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
72
732
0.98
0.03
2.7
2.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
285
2830
1.01
0.03
3.9
4.2
ng/l
260.2
515.6
1.00
231
2423
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
122
1.07
0.02
1.2
1.2
u/ml
2.2
5.9
—
5
55
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
101
1018
0.99
0.01
1.7
1.7
%
1.6
1.6
0.49
87
856
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
109
1080
1.01
0.01
3.8
3.4
ng/l
83.4
93.1
0.60
95
903
(3001019) Free T4 and TSH panel - Serum or Plasma
29
297
0.98
0.01
1.8
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
341
3397
1.00
0.01
4.7
4.2
estimate
0.0
0.0
0.50
129
991
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
147
1476
0.99
0.01
2.1
2.5
ug/l
4.0
7.2
3.63
123
1257
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
11
115
0.96
0.00
1.2
1.2
nmol/l
1.5
1.4
0.09
11
100
(3008037) Lactate [Moles/volume] in Venous blood
36
358
1.00
0.00
4.9
2.9
mmol/l
1.7
1.7
0.08
36
350
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
133
0.98
0.00
1.3
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
148
1.01
0.00
2.8
3.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
32
322
0.99
0.00
1.5
1.6
iu/ml
0.0
0.8
0.58
12
74
(3045424) Erythrocytes [Presence] in Urine
18
176
1.02
0.00
1.4
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
32
323
0.99
0.00
4.1
3.6
mg/l
40.0
29.4
0.55
21
229
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
109
1.01
0.00
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
9
90
1.00
0.00
1.0
1.1
%
86.1
93.9
—
9
84
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
22.0
—
0
7
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
82
0.97
0.00
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
59
1.02
0.00
8.5
5.9
—
68.9
—
0
14
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.7
—
1.9
—
0
7
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
233.3
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
62
0.97
0.00
1.2
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
66
0.91
0.00
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
58
0.86
0.00
1.0
2.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
66
0.91
0.00
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
8
81
0.99
0.00
1.0
1.1
—
185.0
—
0
12
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
5.7
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SECONDARY_WITHOUT_SITESPEC_EXALLC – Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).